FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210366603> ?p ?o ?g. }

• W4210366603 endingPage "969" @default.
• W4210366603 startingPage "960" @default.
• W4210366603 abstract "Immunogenicity to biologics is often observed following dosing in human subjects during clinical trials. Both product and host specific factors may be implicated in contributing to a potential immune response. However, even if such risk factors are identified and eliminated as part of the rational quality by design approaches, the outcome in clinic can be uncertain and challenging to predict. Several tools have been employed to identify these risk factors and consequent mitigation approaches implemented prior to dosing in humans. However, the complexity of the immune system with an interplay of network of immune cells involved in driving a long- term immune response as well as patient characteristics, can make it challenging to predict the outcome in clinic. This perspective will provide an insight into recent advances in the risk assessment approaches that are utilized during preclinical stage of development of a biologic. The outputs from such tools can help to rank order and select the most optimal candidate with the least likelihood of an immune response and can further drive the development of a clinical bioanalytical and immunogenicity monitoring strategy. Such a strategy can be proactively shared with the regulators along with the proposal to streamline clinical immunogenicity and personalizing the outcome based on pharmacogenomics and other patient-related factors. This paper provides a roadmap on performing risk assessments through a systematic identification of risks and their mitigations wherever possible. Recommendations on incorporating the key components of such risk assessments as part of the new regulatory submissions are also provided. Shorter abstract Immunogenicity to biologics is common during clinical trials. Both product and host specific factors have been implicated. Several risk assessment tools can be used to identify and mitigate the risk factors responsible for immunogenicity. An insight into recent advances in the risk assessment approaches will be presented. The outputs can define a risk score and guide the clinical bioanalytical and immunogenicity monitoring strategy. A roadmap on performing risk assessments through a systematic identification of risks and their mitigations wherever possible is provided. Best practices for a risk assessment strategy and recommendations on the content for IND and the Integrated summary of Immunogenicity are also provided." @default.
• W4210366603 created "2022-02-08" @default.
• W4210366603 creator A5006610576 @default.
• W4210366603 creator A5026216217 @default.
• W4210366603 creator A5048454883 @default.
• W4210366603 creator A5057258942 @default.
• W4210366603 creator A5071694497 @default.
• W4210366603 date "2022-04-01" @default.
• W4210366603 modified "2023-10-14" @default.
• W4210366603 title "Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs" @default.
• W4210366603 cites W1944657476 @default.
• W4210366603 cites W1964339501 @default.
• W4210366603 cites W1966025583 @default.
• W4210366603 cites W1970089737 @default.
• W4210366603 cites W1978621527 @default.
• W4210366603 cites W2025122282 @default.
• W4210366603 cites W2029982776 @default.
• W4210366603 cites W2031362503 @default.
• W4210366603 cites W2037201482 @default.
• W4210366603 cites W2044692977 @default.
• W4210366603 cites W2057254671 @default.
• W4210366603 cites W2059385530 @default.
• W4210366603 cites W2064882706 @default.
• W4210366603 cites W2078172351 @default.
• W4210366603 cites W2086437884 @default.
• W4210366603 cites W2092720388 @default.
• W4210366603 cites W2100350770 @default.
• W4210366603 cites W2113202013 @default.
• W4210366603 cites W2114964760 @default.
• W4210366603 cites W2130528924 @default.
• W4210366603 cites W2132280606 @default.
• W4210366603 cites W2140035322 @default.
• W4210366603 cites W2140377154 @default.
• W4210366603 cites W2149350146 @default.
• W4210366603 cites W2150178690 @default.
• W4210366603 cites W2155294390 @default.
• W4210366603 cites W2166304356 @default.
• W4210366603 cites W2169844063 @default.
• W4210366603 cites W2281597363 @default.
• W4210366603 cites W2481068577 @default.
• W4210366603 cites W2517194758 @default.
• W4210366603 cites W2530948814 @default.
• W4210366603 cites W2551782790 @default.
• W4210366603 cites W2578864244 @default.
• W4210366603 cites W2592265634 @default.
• W4210366603 cites W2596236174 @default.
• W4210366603 cites W2610188915 @default.
• W4210366603 cites W2619197807 @default.
• W4210366603 cites W2670890989 @default.
• W4210366603 cites W2671261300 @default.
• W4210366603 cites W2736550573 @default.
• W4210366603 cites W2753400018 @default.
• W4210366603 cites W2760974752 @default.
• W4210366603 cites W2782530467 @default.
• W4210366603 cites W2785439933 @default.
• W4210366603 cites W2807183161 @default.
• W4210366603 cites W2808509820 @default.
• W4210366603 cites W2911342550 @default.
• W4210366603 cites W2946033191 @default.
• W4210366603 cites W3004413935 @default.
• W4210366603 cites W3039467801 @default.
• W4210366603 cites W3113128227 @default.
• W4210366603 cites W3209301640 @default.
• W4210366603 doi "https://doi.org/10.1016/j.xphs.2022.01.032" @default.
• W4210366603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35122828" @default.
• W4210366603 hasPublicationYear "2022" @default.
• W4210366603 type Work @default.
• W4210366603 citedByCount "5" @default.
• W4210366603 countsByYear W42103666032022 @default.
• W4210366603 countsByYear W42103666032023 @default.
• W4210366603 crossrefType "journal-article" @default.
• W4210366603 hasAuthorship W4210366603A5006610576 @default.
• W4210366603 hasAuthorship W4210366603A5026216217 @default.
• W4210366603 hasAuthorship W4210366603A5048454883 @default.
• W4210366603 hasAuthorship W4210366603A5057258942 @default.
• W4210366603 hasAuthorship W4210366603A5071694497 @default.
• W4210366603 hasConcept C112930515 @default.
• W4210366603 hasConcept C116834253 @default.
• W4210366603 hasConcept C142724271 @default.
• W4210366603 hasConcept C170734499 @default.
• W4210366603 hasConcept C177713679 @default.
• W4210366603 hasConcept C203014093 @default.
• W4210366603 hasConcept C2777288759 @default.
• W4210366603 hasConcept C2778917124 @default.
• W4210366603 hasConcept C2780868878 @default.
• W4210366603 hasConcept C41008148 @default.
• W4210366603 hasConcept C535046627 @default.
• W4210366603 hasConcept C59822182 @default.
• W4210366603 hasConcept C60644358 @default.
• W4210366603 hasConcept C70721500 @default.
• W4210366603 hasConcept C71924100 @default.
• W4210366603 hasConcept C86803240 @default.
• W4210366603 hasConcept C8891405 @default.
• W4210366603 hasConcept C98274493 @default.
• W4210366603 hasConceptScore W4210366603C112930515 @default.
• W4210366603 hasConceptScore W4210366603C116834253 @default.
• W4210366603 hasConceptScore W4210366603C142724271 @default.
• W4210366603 hasConceptScore W4210366603C170734499 @default.

• next